News
Orphengesic Forte (orphenadrine citrate, aspirin, caffeine tablets) is now available for mild to moderate pain of acute musculoskeletal disorders.
Orphengesic Forte consists of orphenadrine citrate 50mg, aspirin 770mg, and caffeine 60mg in an oral tablet formulation. It is indicated for the symptomatic relief of mild to moderate pain of ...
Orphengesic Forte is an oral non-controlled combination muscle relaxant pain reliever. The oral tablets contain 50 mg of Orphenadrine Citrate, 770 mg of Aspirin and 60 mg of Caffeine.
“Orphengesic Forte is a proven, safer pain management alternative healthcare providers can consider before prescribing an opioid.” FDA had designated the company’s supplemental abbreviated new drug ...
Orphengesic Forte is an oral non-controlled combination muscle relaxant pain reliever. The oral tablets contain 50 mg of Orphenadrine Citrate, 770 mg of Aspirin and 60 mg of Caffeine.
These combinational therapies reduce the frequency of drug administration. For instance, in May 2019, Galt Pharmaceuticals has submitted a Supplemental Abbreviated New Drug Application to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results